Ameren
AEE
101.32
-0.36
-0.35%
Ameren
US · AEE
#720 by market cap
Listed 1970
101.32
-0.36
-0.35%
Live - 5344 symbols - heartbeat 55s ago
· 2026-10-07 20:02
After-hours
101.32
0.00%
- Market cap
- 28.05B
- P/E (TTM)i
- 17.84
- P/Bi
- 2.05
- EPSi
- 5.35
- Div yieldi
- 2.88%
- 52W posi
- 29%
Reader sentiment
Are you bullish or bearish on AEE?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 0.92, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +15.43% YoY
Margins
- Gross margin
- 47.40%
- Operating margin
- 23.03%
- Net margin
- 16.55%
Key ratios & quality
- Enterprise valuei
- 47.87B
- PEG ratioi
- 1.67
- Altman Z-Scorei
- 0.92
PEG uses trailing P/E against the 3-year net income growth rate (10.68%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 6.29B | 5.91B | 5.79B | 6.39B | 7.96B | 7.50B | 7.62B | 8.80B |
| Gross profit | 2.80B | 2.74B | 2.86B | 2.99B | 3.34B | 3.47B | 3.65B | 4.17B |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.36B | 1.27B | 1.30B | 1.33B | 1.52B | 1.56B | 1.52B | 2.03B |
| Pretax profit | 1.06B | 1.02B | 1.03B | 1.15B | 1.26B | 1.34B | 1.27B | 1.60B |
| Tax | 237.00M | 182.00M | 155.00M | 157.00M | 176.00M | 183.00M | 83.00M | 136.00M |
| Net profit | 821.00M | 834.00M | 877.00M | 995.00M | 1.08B | 1.16B | 1.19B | 1.46B |
| Basic EPS | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 5 |
| Diluted EPS | 3.32 | 3.35 | 3.50 | 3.84 | 4.14 | 4.38 | 4.42 | 5.35 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 2.10B | 2.22B | 2.70B | 1.78B | 2.18B | 2.09B |
| Gross profit | 941.00M | 928.00M | 1.40B | 898.00M | 1.08B | 1.03B |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 430.00M | 411.00M | 825.00M | 360.00M | 532.00M | 459.00M |
| Pretax profit | 340.00M | 320.00M | 693.00M | 244.00M | 418.00M | 368.00M |
| Tax | 50.00M | 43.00M | 52.00M | -9.00M | 60.00M | 52.00M |
| Net profit | 290.00M | 277.00M | 641.00M | 253.00M | 358.00M | 316.00M |
| Basic EPS | 1 | 1 | 2 | 1 | 1 | 1 |
| Diluted EPS | 1.07 | 1.01 | 2.35 | 0.92 | 1.28 | 1.13 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.53B | 1.43B | 1.65B | 1.97B | 2.67B | 2.18B | 2.26B | 2.57B |
| Cash & ST investments | 16.00M | 16.00M | 139.00M | 16.00M | 250.00M | 25.00M | 7.00M | 13.00M |
| Inventory | 483.00M | 494.00M | 521.00M | 592.00M | 667.00M | 733.00M | 762.00M | 774.00M |
| Total assets | 27.22B | 28.93B | 32.03B | 35.74B | 37.90B | 40.83B | 44.60B | 48.48B |
| Total current liabilities | 2.69B | 2.51B | 2.18B | 2.83B | 3.37B | 3.35B | 3.41B | 3.91B |
| Short-term debt | 1.18B | 882.00M | 498.00M | 1.05B | 1.41B | 1.39B | 1.46B | 1.62B |
| Long-term debt | 7.86B | 8.92B | 11.08B | 12.56B | 13.69B | 15.12B | 17.26B | 18.21B |
| Total liabilities | 19,442,000,000.00 | 20,732,000,000.00 | 22,950,000,000.00 | 25,906,000,000.00 | 27,267,000,000.00 | 29,352,000,000.00 | 32,355,000,000.00 | 34,946,000,000.00 |
| Total equity | 7.77B | 8.20B | 9.08B | 9.83B | 10.64B | 11.48B | 12.24B | 13.53B |
| Retained earnings | 2.02B | 2.38B | 2.76B | 3.18B | 3.65B | 4.14B | 4.60B | 5.29B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 2.46B | 2.47B | 2.61B | 2.57B | 2.57B | 2.64B |
| Cash & ST investments | 23.00M | 11.00M | 9.00M | 13.00M | 13.00M | 12.00M |
| Inventory | 669.00M | 738.00M | 804.00M | 774.00M | 733.00M | 800.00M |
| Total assets | 45.67B | 46.63B | 47.42B | 48.48B | 49.85B | 51.22B |
| Total current liabilities | 2.86B | 3.09B | 2.81B | 3.91B | 4.13B | 4.98B |
| Short-term debt | 1.27B | 1.17B | 932.00M | 1.62B | 2.30B | 2.74B |
| Long-term debt | 18.35B | 18.81B | 19.17B | 18.21B | 19.00B | 19.06B |
| Total liabilities | 33,317,000,000.00 | 34,182,000,000.00 | 34,507,000,000.00 | 34,946,000,000.00 | 36,161,000,000.00 | 37,400,000,000.00 |
| Total equity | 12.35B | 12.44B | 12.91B | 13.53B | 13.69B | 13.82B |
| Retained earnings | 4.70B | 4.78B | 5.23B | 5.29B | 5.44B | 5.55B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 2.17B | 2.17B | 1.73B | 1.66B | 2.26B | 2.56B | 2.76B | 3.35B |
| Depreciation & amortization | 1.03B | 1.08B | 1.15B | 1.28B | 1.44B | 1.50B | 1.61B | 1.67B |
| Free cash flow | -168.00M | -272.00M | -1.57B | -1.86B | -1.12B | -1.21B | -1.65B | -821.00M |
| Dividends paid | -451.00M | -472.00M | -494.00M | -565.00M | -610.00M | -662.00M | -714.00M | -768.00M |
| Stock buybacks / issuance | 74.00M | 68.00M | 476.00M | 308.00M | 333.00M | 346.00M | 273.00M | 574.00M |
| Ending cash balance | 107.00M | 176.00M | 301.00M | 155.00M | 216.00M | 272.00M | 328.00M | 420.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 431.00M | 862.00M | 1.10B | 956.00M | 421.00M | 770.00M |
| Depreciation & amortization | 415.00M | 398.00M | 425.00M | 430.00M | 438.00M | 446.00M |
| Free cash flow | -651.00M | -205.00M | 115.00M | -80.00M | -1.18B | -310.00M |
| Dividends paid | -191.00M | -193.00M | -192.00M | -192.00M | -208.00M | -206.00M |
| Stock buybacks / issuance | 13.00M | 12.00M | 10.00M | 539.00M | 12.00M | 10.00M |
| Ending cash balance | 376.00M | 394.00M | 435.00M | 420.00M | 485.00M | 470.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 11.00 | 10.55 | 10.25 | 10.62 | 10.63 | 10.54 | 10.08 | 11.41 |
| ROA %i | 3.07 | 2.95 | 2.86 | 2.92 | 2.92 | 2.93 | 2.77 | 3.13 |
| ROIC %i | 6.82 | 6.45 | 6.40 | 6.03 | 5.98 | 6.03 | 6.00 | 6.63 |
| 5-year avg ROE %i | 9.14 | 9.48 | 9.68 | 9.95 | 10.61 | 10.52 | 10.42 | 10.66 |
| EBIT margin %i | 23.19 | 23.64 | 25.04 | 24.01 | 21.88 | 25.41 | 25.36 | 26.97 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Current ratioi | 0.57 | 0.57 | 0.76 | 0.70 | 0.79 | 0.65 | 0.66 | 0.66 |
| Quick ratioi | 0.32 | 0.30 | 0.41 | 0.30 | 0.40 | 0.28 | 0.29 | 0.31 |
| Debt / assetsi | 33.20 | 33.86 | 36.14 | 38.09 | 39.82 | 40.43 | 41.98 | 40.91 |
| LT debt / equityi | 102.99 | 110.62 | 123.94 | 129.51 | 130.23 | 133.24 | 142.50 | 135.92 |
| Interest coveragei | 3.64 | 3.67 | 3.46 | 4.01 | 3.58 | 3.37 | 2.92 | 3.06 |
| Revenue CAGR (3Y) %i | 1.04 | -0.92 | -2.10 | 0.54 | 10.42 | 8.98 | 6.04 | 3.41 |
| Net income CAGR (3Y) %i | 8.96 | 8.24 | 18.53 | 6.70 | 9.06 | 9.77 | 6.09 | 10.68 |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 10.23 | 10.29 | 11.47 | 11.41 | 11.83 | 12.02 |
| ROA %i | 2.78 | 2.76 | 3.11 | 3.13 | 3.19 | 3.20 |
| ROIC %i | 5.97 | 5.99 | 6.57 | 6.63 | 6.67 | 6.74 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 25.15 | 24.09 | 25.06 | 26.97 | 27.93 | 29.15 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 0.86 | 0.80 | 0.93 | 0.66 | 0.62 | 0.53 |
| Quick ratioi | 0.44 | 0.37 | 0.46 | 0.31 | 0.29 | 0.26 |
| Debt / assetsi | 42.97 | 42.85 | 42.40 | 40.91 | 42.74 | 42.58 |
| LT debt / equityi | 150.21 | 152.76 | 150.02 | 135.92 | 140.18 | 139.29 |
| Interest coveragei | 2.91 | 2.88 | 3.03 | 3.06 | 3.08 | 3.08 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Ameren Missouri is the largest reported line at 53.73% of revenue, across 5 reported segments.
- Ameren Illinois Electric Distribution follows at 30.07%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Ameren Missouri53.73%
Ameren Illinois Electric Distribution30.07%
Ameren Transmission10.95%
Ameren Illinois Natural Gas8.41%
Quote time 2026-10-07 20:02:33 · For reference only, not investment advice and not tailored to your situation.